Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Blood (2019) 134 (Supplement_1): 1200.

https://doi.org/10.1182/blood-2019-132005

Published: 2019

Journal Articles

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Martin W. Schoen, MDMPH, Peter Georgantopoulos, MS, Nagasai S Yalavarthi, BS, Charles L. Bennett, MD PhD

Blood (2019) 134 (Supplement_1): 2135.

https://doi.org/10.1182/blood-2019-121770

Published: 2019

Journal Articles

Beyond Cytosine Methylation: Ten-Eleven Translocation Proteins, Oxidized Methylcytosines, and Cancer

Anjana Rao, PhD

Blood (2017) 130 (Supplement 1): SCI-51.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-51.SCI-51

Published: 2017

Journal Articles

TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies

Edward F Greenberg, MD, Cassandra M. Hirsch, BS, Feng Pan, PhD, Babal K Jha, PhD, Yihong Guan, PhD, Valeria Visconte, PhD, Dewen You, PhD, Guangbo Qu, PhD, Amy Graham, Bartlomiej P. Przychodzen, MSc, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Daniel Gackowski, PhD, Ryszard Ólinski, Professor, Yu-Wei Cheng, PhD, Mikkael A. Sekeres, MD MS, Mingjiang Xu, MDPhD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1668.

https://doi.org/10.1182/blood.V130.Suppl_1.1668.1668

Published: 2017

Journal Articles

Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications

Edward F Greenberg, MD, Cassandra M. Hirsch, BS, Shi Chen, Xiaochen Liiu, Babal K Jha, PhD, Valeria Visconte, PhD, Dewen You, PhD, Bartlomiej P. Przychodzen, MSc, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Aziz Nazha, MD, Mingjiang Xu, MDPhD, Daniel Gackowski, PhD, Mridul Mukherji, D.Phil., Mikkael A. Sekeres, MD MS, Ryszard Ólinski, Professor, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1205.

https://doi.org/10.1182/blood.V130.Suppl_1.1205.1205

Published: 2017

Journal Articles

Tet2 Loss Dysregulates the Behavior of Mesenchymal Stem Cells and Increases Their Ability to Promote Tet2 -/- -Driven Myeloid Malignancy Progression

Zhigang Zhao, MD PhD, Rong Li, Lin Liu, Jinhuan Wang, Zizhen Chen, Wen Xing, MD, Weiping Yuan, PhDMD, Feng-Chun Yang, MD PhD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD

Blood (2016) 128 (22): 1510.

https://doi.org/10.1182/blood.V128.22.1510.1510

Published: 2016

Journal Articles

Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).

Rosetta Martiniello-Wilks, BSc (Hons), PhD, Stephen R. Larsen, MBBS(Hons), Stephane Flamant, BSc (Hons), PhD, Jessamy C. Tiffen, BSc (Hons), Charles G. Bailey, BSc (Hons), PhD, John E.J. Rasko, BSc(Med), MBBS, PhD

Blood (2007) 110 (11): 5148.

https://doi.org/10.1182/blood.V110.11.5148.5148

Published: 2007

Journal Articles

Breakthrough C. parapsilosis (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem Cell (HSC) Recipients Receiving Long Term Caspofungin (C) Therapy.

Nabil Kabbara, MD, Claire Lacroix, MD, Marie Robin, MD, Vanderson Rocha, MD, PHD, Regis Peffault de Latour, MD, Helene Esperou, MD, Agnes Devergie, MD, Eliane Gluckman, MD, PHD, Gerard Socie, MD, PHD, Patricia Ribaud, MD

Blood (2006) 108 (11): 5269.

https://doi.org/10.1182/blood.V108.11.5269.5269

Published: 2006

Journal Articles

Co-Expression of the UPRT Gene with the Human Nerve Growth Factor Receptor and Cytosine Deaminase Fusion Gene Using a Single Retroviral Vector Augments Cytotoxicity of Transduced Human T-Cells Exposed to 5-Fluorocytosine.

Tracey A. O’Brien, Dong T. Tuong, Lisa M. Basso, Paul J. Orchard

Blood (2004) 104 (11): 5244.

https://doi.org/10.1182/blood.V104.11.5244.5244

Published: 2004

Journal Articles

Cytosine Deaminase Adenoviral Vector and 5-Fluorocytosine Selectively Reduce Breast Cancer Cells 1 Million-Fold When They Contaminate Hematopoietic Cells: A Potential Purging Method for Autologous Transplantation

Blood (1998) 92 (2): 672–682.

https://doi.org/10.1182/blood.V92.2.672

Published: 1998

NARROW

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment

Beyond Cytosine Methylation: Ten-Eleven Translocation Proteins, Oxidized Methylcytosines, and Cancer

TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies

Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications

Tet2 Loss Dysregulates the Behavior of Mesenchymal Stem Cells and Increases Their Ability to Promote Tet2 -/- -Driven Myeloid Malignancy Progression

Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).

Breakthrough C. parapsilosis (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem Cell (HSC) Recipients Receiving Long Term Caspofungin (C) Therapy.

Co-Expression of the UPRT Gene with the Human Nerve Growth Factor Receptor and Cytosine Deaminase Fusion Gene Using a Single Retroviral Vector Augments Cytotoxicity of Transduced Human T-Cells Exposed to 5-Fluorocytosine.

Cytosine Deaminase Adenoviral Vector and 5-Fluorocytosine Selectively Reduce Breast Cancer Cells 1 Million-Fold When They Contaminate Hematopoietic Cells: A Potential Purging Method for Autologous Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only